The discovery of a new drug class for the acute treatment of migraine.
The history of the scientific ideas and events that led to the discovery of sumatriptan is outlined with personal reminiscences about individuals who influenced the approach. The development of sumatriptan revolutionized the acute treatment of migraine and led to the availability of a number of other triptans. The anti-migraine effects of all the triptans are mediated via 5-HT(1B), and possibly 5-HT(1D) receptors, which transduce their effects via G; proteins. This suggests that agonists at other G(i) protein-coupled receptor types appropriately located (eg, somatostatin sst(2), adenosine A(1)) should be examined for their effects on the trigeminovascular system, Studies on such receptor targets may provide insight into a novel approach towards the design of new anti-migraine drugs.
Humphrey
Patrick P A
PP
Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA 94080, USA.
D019204:GTP-Binding Proteins / Q000502:physiology; D049673:History, 20th Century; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D011985:Receptors, Serotonin / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D014363:Tryptamines / Q000266:history* / Q000627:therapeutic use*
D011985:Receptors, Serotonin; D014363:Tryptamines; D012701:Serotonin; D019204:GTP-Binding Proteins